Taisho Pharmaceutical Holdings Co., Ltd.

GPTKB entity

Properties (58)
Predicate Object
gptkbp:instanceOf gptkb:Company
gptkbp:acquisition Various brands
Various pharmaceutical companies
gptkbp:awards Various industry awards
gptkbp:CEO Katsuhiko Takeda
gptkbp:collaborations Academic institutions
Research organizations
Healthcare_providers
gptkbp:corporateSocialResponsibility Community health initiatives
Ethical business practices
Employee welfare programs
gptkbp:employees over 3,000
gptkbp:establishedIn 20th century
gptkbp:financialPerformance Strong revenue growth
Increasing market share
Stable_profit_margins
gptkbp:founded 1912
gptkbp:founder gptkb:Taisho_Pharmaceutical_Co.,_Ltd.
gptkbp:futurePlans Expansion into new markets
Investment in biotechnology
Enhancement of product lines
gptkbp:globalPresence gptkb:Asia
gptkb:North_America
Europe
gptkbp:headquarters gptkb:Tokyo
gptkb:Tokyo,_Japan
https://www.w3.org/2000/01/rdf-schema#label Taisho Pharmaceutical Holdings Co., Ltd.
gptkbp:industry Pharmaceuticals
gptkbp:innovation Advanced manufacturing processes
New drug formulations
Digital_health_solutions
gptkbp:investmentFocus Research and development
gptkbp:keyPeople Katsuhiko Takeda
gptkbp:market gptkb:Japan
gptkbp:marketSegment Global expansion
Product diversification
Consumer-focused marketing
gptkbp:parentCompany gptkb:Taisho_Pharmaceutical_Co.,_Ltd.
gptkbp:partnerships Various international pharmaceutical companies
gptkbp:philanthropy Disaster relief efforts
Health initiatives
Education support
gptkbp:products Cosmetics
Medical devices
Prescription drugs
Health supplements
Over-the-counter drugs
gptkbp:researchFocus Innovative drug development
OTC products
Generic_drugs
gptkbp:revenue ¥100 billion (approx.)
gptkbp:subsidiary gptkb:Taisho_Pharmaceutical_Co.,_Ltd.
gptkbp:sustainabilityInitiatives Community engagement
Health and wellness programs
Environmental responsibility
gptkbp:tradedOn gptkb:Tokyo_Stock_Exchange
gptkbp:type Public company
gptkbp:website www.taisho-holdings.co.jp